• Medicine 1

    When patients are involved, medical research results become meaningful solutions

  • Medicine 2

    We provide patient input to the latest research for chronic diseases

  • Medicine 3

    Improving patient knowledge and involvement in clinical trials

WHO first global air pollution conference
This October, the World Health Organisation held the first global air pollution conference. With 7 million people dying from air pollution each year, including 600 000 children, putting COPD, asthma a ...

Read more

Capacity Building webinars
As announced in our October newsletter, our Capacity Building project is up and running with a new format to allow all our members to participate and benefit from it. We started the webinar series a ...

Read more

It’s Vaccination Season!
Autumn is passing and winter coming, are you thinking about whether to get the vaccination against influenza, also known as the flu? And what about the pneumococcal vaccination against pneumonia? Thes ...

Read more

The EU Health policy platform: a health meeting point
On the 12th November 2018 EFA Director of Policy and Communications Isabel Proaño participated in the EU Health Policy Platform (HPP) Annual Stakeholder Meeting. The HPP is a European Commission forum ...

Read more

ERS-ENSP event: “H2020 funding for Tobacco Control: Scaling up for the prevention of lung diseases in the EU "
On 18th October the European Respiratory Society (ERS) and the European Network for Smoking and Tobacco Prevention (ENSP) organised an event on “H2020 funding for Tobacco Control: Scaling up for the p ...

Read more

Recommendations for Personalized Medicine from the European PRECeDI project
On 7th of November we attended the final conference in Brussels of the EU-funded research project Personalized PREvention of Chronic DIseases (PRECeDI). The project aims to promote knowledge transfer  ...

Read more

EFA re-newed as EMA eligible organisation
Following an annual assessment, the European Medicines Agency (EMA), the European Union agency for the evaluation of medicinal products, confirmed the continued compliance of EFA with the criteria req ...

Read more

We discussed Digital Health workshop at the Committee of the Regions
On 25th October 2018, we were invited as speaker in the “Digital Health for all” workshop, organised by the Regional Ministry of Health of Andalusia (Andalusia Reference Site) in collaboration with th ...

Read more

The European Patients Forum's manifesto is launched!
During a launch event on 9th October, the European Patients’ Forum launched a Manifesto calling on the political leaders of the EU, Members of the European Parliament and the future Commission, to ens ...

Read more

HEAL’s Annual General Meeting
In October 17-18, EFA Director of Policy and Strategy Isabel Proaño participated in the Annual General Assembly of the Health and Environment Alliance (HEAL) to share best practices and move forward.  ...

Read more

FENAER launches a shock-plan on tobacco, COPD and spirometry in Spain
In November, EFA Spanish Member FENAER launched an ambitious plan to improve diagnosis and reduce COPD deaths in Spain. The organisation has been presenting the plan to several local health ministries ...

Read more

EFA becomes official NGO to WHO Europe
On September 20 the WHO Regional Committee for Europe adopted a decision in plenary to accredit 19 not for profit organisations, including EFA, into ‘regional non-state actors’. In other words, EFA is ...

Read more

Horizon Europe must deliver on citizens’ priorities: the case of allergy and asthma
The European Parliament Interest Group on Allergy and Asthma held a policy meeting on October 9 to overcome the barriers to research in NCDs in Europe. Key opinion leaders in clinical research from th ...

Read more

European Atopic Eczema Day
Last September 14th the atopic eczema patient community belonging to EFA’s Members marked the first ever European Atopic Eczema Awareness Day to inform and bring attention to this allergic disease  ...

Read more

The involvement of patients in HTA becomes secondary for the European Parliament
On October 3, the European Parliament plenary adopted in the first reading the file on the proposal for a regulation of the European Parliament and of the Council on health technology assessment (HTA) ...

Read more

Personalised Medicine alliance discusses HTA at Parliament
On September 26, the European Alliance for Personalised Medicine (EAPM) organised a Roundtable in the European Parliament to discuss how to coordinate Health Technology Assessment between Member  ...

Read more

European Commission report on cross-border healthcare Directive shows it helps clarify patients' rights
On 21 September, the European Commission published an implementation report on the directive on cross-border healthcare (2011/24/EU). The concept of the cross-border healthcare directive has the poten ...

Read more

WHO - Life expectancy is on the rise in Europe but caveats for allergy and respiratory health remain
The newest European Health report by the World Health Organisation published on 12 September, shows that life we live longer in Europe. The European Health report is published every three years and is ...

Read more

Hearing on vaccination programmes and health systems in Europe
In the light of the recent vaccine hesitancy trend, the European Commission Expert Panel on Effective Ways of Investing In Health is working on “vaccination programmes and health systems in Europe”. V ...

Read more

The Human Biomonitoring in Europe, or how to assess our exposure to chemicals
On 28 September the Austrian EU Presidency organised in Vienna a major European conference on the health effects of environmental chemicals. The conference entitled "Human Biomonitoring in Europe -  ...

Read more

What's new - Clinical trials

Last September 14th the atopic eczema patient community belonging to EFA’s Members marked the first ever European Atopic Eczema Awareness Day to inform and bring attention to this allergic disease  ...

Read more...

In July, our Director Susanna Palkonen chaired a meeting on behalf of the European Patients’ Forum and coordinated by the Association of Medical Research Charities UK (AMRC) to meet the Brexit taskfor ...

Read more...

Latest research - Clinical trials

EFA organised the final event of AirPROM, an EU funded project that during five years has pulled out the best knowledge of lung research in Europe to come up with a virtual model of the human lungs. E ...

Read more...

On the 9th of September, the Chair of the EFA COPD Working Group, Michael Wilken, represented COPD patients’ views on the IMI GetReal COPD case study workshop held in Frankfurt, Germany. Launched in ...

Read more...

Key Facts

4,000 clinical trials
are authorised each year in the European Economic Area (EEA)

61% of clinical trials
are sponsored by the pharmaceutical industry

39% of clinical trials
are sponsored by non-commercial sponsors, mainly academia